Pancreatic Cancer Research

ResearcherChina Medical UniversityActive in the last 2 years

Wan‐Jou Shen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109301306. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. AMIGO2 as a Novel Biomarker Predicting Poor Prognosis and Associated with Adhesion-Driven Metastasis in Pancreatic Adenocarcinoma. Co-author DOI 10.7150/ijms.121794↗
  2. Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.7150/ijms.96134↗
  3. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines9111601↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ze-Syuan Chen · 1 shared paper, 2026 · strength 0.32
  2. Wei-jan Wang · 1 shared paper, 2026 · strength 0.32
  3. Wei‐Jan Wang · 2 shared papers, 2021–2024 · strength 0.31
  4. Cheng‐Wei Chou · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.